George R. Bailie, Pharm.D., Ph.D.

Professor Emeritus of Nephrology Pharmacy
Department of Pharmacy Practice, Albany Campus
Tel: (518) 694-7235
E-mail: george.bailie@acphs.edu

Education:

• Ph.D., University of Wales
  
  Pharm.D., University of Minnesota
  
  MSc (Pharmacology), University of Strathclyde, Glasgow
  
  BSc (Pharmacy), Queen’s University of Belfast

Courses Taught at ACPHS:

• Nephrology in PT4

Research Interests:

• Optimization of medication use in patients with kidney disease.

Selected Publications:

• Bailie GR, Elder SJ, Mason NA, et al. Sexual Dysfunction in Dialysis Patients Treated with Antihypertensive or Antidepressive Medications: Results from the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant 2007; 22:1163-1170.
  
  Bragg-Gresham JL, Fissell RB, Mason NA, Bailie GR, et al. Diuretic use, residual renal function and mortality among hemodialysis patients in DOPPS. Am J Kidney Dis 2007;49:426-431.
  
  Cavill I, Auerbach M, Bailie GR, Barrett-Lee P, Beguine Y, Kaltwasser P, Littlewood T, Macdougall IC, Wilson K. Iron and the anaemia of chronic disease: a review and strategic recommendations. Curr Med Res Opin 2006, 22: 731-737.
  
  Van Wyck DB, Eckardt K-U, Adamson JW, Bailie GR, et al. National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis 2006, 47 (Suppl 3): S1-S146.
  
  Elwell RJ, Manley HJ, Frye RF, Bailie GR. Pharmacokinetics of intraperitoneal cefazolin and ceftazidime coadministered to CAPD patients. Int J Artif Organs 2006;28:808-816.
  
  Bailie GR, Mason NA, Elder SJ, Andreucci VE, Greenwood RN, Akiba T, Saiyo A, Bragg-Gresham JL, Gillespie BW, Young EW. Large variations in prescriptions of gastrointestinal medications in hemodialysis patients on three continents: The Dialysis Outcomes and Practice Patterns Study. Hemodialysis Int 2006;10:180-188.
  
  Elwell RJ, Manley HJ, Frye RF, Bailie GR. Pharmacokinetics of intraperitoneal cefazolin and ceftazidime coadministered to CAPD patients. Int J Artif Organs 2006;28:808-816.
  
  Bailie GR, Mason NA, Elder SJ, Andreucci VE, Greenwood RN, Akiba T, Saiyo A, Bragg-Gresham JL, Gillespie BW, Young EW. Large variations in prescriptions of gastrointestinal medications in hemodialysis patients on three continents: The Dialysis Outcomes and Practice Patterns Study. Hemodialysis Int 2006;10:180-188.
  
  Mason NA, Bailie GR, Satayathum S, Bragg-Gresham JL, Akiba T, Akizawa T, Combe C, Rayner HC, Saito A, Gillespie BW, Young EW. HMG-coenzyme A reductase inhibitor use is associated with mortality reduction in hemodialysis patients. Am J Kidney Dis 2005, 45: 119-126.
  
  Bailie GR, Eisele G, Liu L, Roys E, Kiser M, Finkelstein F, Wolfe R, Port F, Burrows-Hudson S, Saran R. Patterns of medication use in the RRI-CKD Study: focus on medications with cardiovascular effects. Nephrol Dial Transplant 2005;20:1110-1115.
  
  Bailie GR, Clark JA, Lane CE, Lane PL. Hypersensitivity reactions and deaths associated with intravenous iron preparations. Nephrol Dial Transplant 2005;20:1443-1449.

Affiliations:

• Albany Nephrology Pharmacy (ANephRx) Group
  
  Adjunct Faculty, Division of Nephrology, Albany Medical Center